E&S Healthcare promises a healthier life for mankind.
11
Breast Cancer In Vitro Diagnostic Kit, 'DxMe® BC Kit,' designated as a World-Class Product in Korea(Minstry of Trade, industry and Energy)
10
DxMe® BC Breast Cancer Diagnostic Kit, designated as an innovative medical device (Ministry of Food and Drug Safety)
06
Certification of Korea Good Manufacturing Practice of In-Vitro Diagnostic Devices (KGMP, MFDS)
04
The 4th investment attraction of 2.2 billion
12
Designated as a KRIBB family company
10
Relocation of headquarters (International Science Business Belt_Dungok District)
08
Designated as a high-tech company (Ministry of Science and Technology Information and Communication)
07
Venture business confirmation certification (5th round)
06
DxMe®BC Kit won the grand prize in the tumor marker cancer diagnosis category of the American Clinical Association (AACC)
04
The 3rd investment attraction of 3 billion
07
Inno-Biz certification (Inno-Biz, Ministry of SMEs and Startups)
02
ISO 13485: 2016 (Medical device-quality management system) certification (BSI, UK Malaysia registration of DxMe®BC Kit
01
Registered as a small business in the United States
07
Venture company certificate
06
Certification of medical device manufacturing and quality control standards (KGMP, MFDS) ELSURETM(ELISA automated equipment) mass production model under development Selected as a technology commercialization capability enhancement project in 2020
01
Demeonstration and R&D Projet for promotion of Regulation Free Special Zone
12
Certification of special case for demonstration in the Regulation Free Zone
08
Secondary investment of KRW 9 billion
07
Designated as a start-up leap package support project
09
Registered as a small business in the United States
08
Inno-Biz certification (Inno-Biz, Ministry of SMEs and Startups)
07
Venture company certificate
06
Malaysian government-supported DxMe® BC breast cancer diagnostic kit demonstration
02
ISO 13485: 2016 (Medical device-quality management system) certification (BSI, UK)
12
Preparation for Malaysian government-supported DxMe® BC breast cancer diagnostic kit demonstration
10
Application for permit of DxMe® BC Breast Cancer Diagnostic Kit in Brazil (ANVISA)
04
Designated as Research and Business Development (R&BD) by the Ministry of Commerce, Industry and Energy (Organizing institution)
01
Cooperation with Sao Paulo University in Brazil to advance into the South American market
11
Primary investment of KRW 2.6 billion
09
Launched breast cancer screening project with Malaysian Cancer Foundation
07
Venture company certificate
05
Certification of medical device manufacturing and quality control standards (KGMP, MFDS)
02
Registered DxMe® BC breast cancer diagnostic kit in Netherlands, and Europe
11
CE Marking
08
Item (for export) permission (MFDS) Medical device manufacturing permit (MFDS)
03
ISO13485 (Medical device-quality management system) certification (TÜV SÜD)
07
Venture company certificate
06
Recognized as an affiliated Research Institute of E&S Healthcare Co., Ltd.
02
Acquisition of GMP production facility
12
Signed technology transfer agreement with Pai Chai University Industry-Academic Cooperation Center
11
Founded